Miliary tuberculosis following negative latent tuberculosis infection screening prior to tumor necrosis factor-α antagonists: implications for management?

J Rheumatol. 2012 Jun;39(6):1297-8. doi: 10.3899/jrheum.111577.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Adalimumab
  • Adult
  • Antibodies, Monoclonal, Humanized / adverse effects*
  • Antirheumatic Agents / adverse effects*
  • Arthritis, Psoriatic / drug therapy*
  • False Negative Reactions
  • Female
  • Humans
  • Immunocompromised Host
  • Latent Tuberculosis / chemically induced*
  • Latent Tuberculosis / diagnosis
  • Latent Tuberculosis / immunology
  • Mass Screening*
  • Radiography, Thoracic
  • Tuberculin Test
  • Tumor Necrosis Factor-alpha / antagonists & inhibitors*

Substances

  • Antibodies, Monoclonal, Humanized
  • Antirheumatic Agents
  • Tumor Necrosis Factor-alpha
  • Adalimumab